Chulalongkorn University

Chula to Accelerate Research on “Rutin” — An Herbal Extract Against COVID-19

30-Apr-2021 8:55 AM EDT, by Chulalongkorn University

Newswise — Chula researchers have found that “rutin” extract from orange peel can kill the COVID-19 virus.  They are developing it into drugs while pointing out that drug research is still necessary along with vaccine research and suggesting that Thai people should adjust their views on herbs to create added value.

Around the world, all hands are on deck against the clock to cope with the COVID-19 pandemic, including vaccine research and antiviral drugs study. Several herbs have been mentioned as potentially viable. Chulalongkorn, as a leader in herbal research, has been in search of chemical compounds that are effective against COVID-19, and recently held the third seminar in the “CHULA the Impact” seminar series, entitled “Innovative Herbal Medicine Against COVID-19“. On the panel were, Dr. Kittikhun Wangkanon and Asst. Prof. Dr.  Thanyada Rungrojmongkol of the Department of Biochemistry, Faculty of Science, and Assoc. Prof. Dr. Siwaporn Boonyasuppayakorn of the Department of Microbiology, Faculty of Medicine, to provide updates on the progress of Thai herbal research for the production of modern medicines to attack the viral protease and put an end to the pandemic.

                              Dr. Kittikhun Wangkanon, Department of Biochemistry, Faculty of Science, Chulalongkorn University
                                                           
                                                                  Dr. Kittikhun Wangkanon
                             Department of Biochemistry, Faculty of Science, Chulalongkorn University

 

Decoding Protease to Fight the Outbreak

Protease is one of the first protein-digesting enzymes of the coronavirus 2019 that received attention from Chinese scientists, followed by England, Germany, and the United States. Chula’s Department of Biochemistry, Faculty of Science, is the first and only institution in Thailand capable of studying the structure of the synthesized COVID-19 protease at the molecular level.

“Our research team has been studying the COVID-19 virus at the molecular level. We put the protease crystals under an X-ray that allows us to see what they look like. We can see how the metaphorical “mouth and teeth” of the virus perform different functions, and how to use certain chemical structures to plug them up”, explained Dr. Kittikhun.

“Why protease research? Proteases are necessary for the life cycle of viruses, as they digest the proteins that the viruses built to function. Moreover, proteases rarely change their position in the viral structure even after mutation.”

                                               Active site of SARS-CoV-2 Main Protease

Chula Research Team has studied over 300 herbs, both in the forms of extracts and computer-generated simulations. Many have been found to contain flavonoids that are effective in inhibiting protease in COVID-19.

“Once their anti-COVID-19 test results are satisfactory, the herbs’ chemical compound will be processed to synthesize new and more effective substance in targeting the proteases.”

“Then, the synthesized compounds will be tested against the virus or protease in test tubes in conjunction with computer simulations repeatedly until we think we have derived excellent and interesting compounds that we could proceed to test them on animals and humans,” Dr. Kittikhun added.

 

Rutin: Currently the Most Interesting Antiviral Compound

Rutin is a flavonoid that has powerful antioxidant, anti-inflammatory, antiviral, and antibacterial properties.  Since the onset of the COVID-19 pandemic, it has caught the attention of many researchers overseas as a potential drug to fight the virus.

“Rutin is found in almost all plants, not only in citrus peels, which have a high level of it.  Another type of flavonoid similar to rutin is “baicalein” which is abundantly found in the Indian Trumpet Flower plant (Oroxylum indicum).  Asst. Prof. Dr. Warinthorn Chavasiri of Chula Department of Chemistry has already synthesized these two compounds for further tests”, continued Dr. Kittikhun.

The Chula biochemistry research team is the first to prove rutin’s anti-COVID-19 properties in test tubes and is in the process of publishing the findings.

 

Vaccines Are Not the Final Answers

Learnings from past pandemics show that vaccines alone cannot cope with the scope and rapidity of the outbreak.  The severity of each viral outbreak is different.  Ebola, for example, though not spreading widely is deadly, while the cold, the flu, or the coronavirus spread severely in a large area in the beginning and a few years down the road will naturally become less severe and localized eventually.  Therefore, drugs and vaccine researches must be done alongside.

“We cannot rest our hopes only on vaccines alone.  We don’t know if the vaccines could stay effective for a long time or if they have to be renewed yearly.  Flu vaccines that we receive every year can only protect against 3-4 strains that the Ministry of Public Health predicted would spread that year.  The next year, there may be other strains.  So, drug production has to go hand in hand with the vaccines,” Dr. Kittikhun reiterated about the importance of drug research and manufacturing.

 

Investment for the Future

The experience gained from SARS and MERS years ago helped hasten the COVID-19 vaccine creation.  Drug production is a different matter.  It takes time and risks failure. 

“Medicine development is a very time-consuming process, without any assurance of success. Yet, it is surely useful. One should not forget that scientists could develop the COVID-19 vaccine quickly because of previous knowledge gained from MERS and SARS epidemic. As the virus mutates, or new viruses emerge, we won’t start from scratch. Similarly, in medicine, we were able to develop HIV antiretroviral drugs very quickly in the past because we had already studied similar groups of antiviral drugs before”, Dr. Kittikhun said.

 

Opportunities of Thai Herbs to be Developed as Modern Medicine

Thailand has many kinds of medicinal plants and herbal medicine recipes.  Thai people are familiar with the use of many herbal medicines such as “Fah Talai Jone” or Green chiretta, white and black finger roots, and Curcuma comosa, etc.  However, these familiar herbs lack further development into modern medicines.

“In my opinion, modern and herbal medicines are no different at all, because they both have chemicals that can bind with the proteins, DNA, or our cells.”

Dr. Kittikhun explained that herbs generally contain many compounds, some of which can cause side effects or are toxic. But herbal plant research for medicinal uses is a different matter. Researchers will extract only certain active substances and cast out other unwanted compounds, then modify their structures until they qualify as medicines.

“From an economic standpoint, pulverizing the herbs and encapsulate them is just reselling cheap products repeatedly. Other countries don’t have to depend on us for their livelihoods. In countries overseas, when they discovered important chemicals in medicinal plants, they further developed them into modern medicine with clear indications of properties, toxicity, dosage, and directions for use.  Then they turn around and sell to Thai people at a high price. This is what we must overcome”, Dr. Kittikhun concluded.

 



Filters close

Showing results

110 of 5857
Released: 22-Jun-2021 5:10 PM EDT
Tecnología de inteligencia artificial y ECG puede rápidamente descartar infección por COVID-19
Mayo Clinic

La inteligencia artificial puede ofrecer un manera de determinar con exactitud que una persona no está infectada con la COVID-19. Un estudio internacional y retrospectivo descubrió que la infección por SARS-CoV-2, el virus que causa la COVID-19, provoca sutiles cambios eléctricos en el corazón. Un electrocardiograma (ECG) mediado por inteligencia artificial detecta estos cambios y puede servir como una prueba rápida y confiable para descartar la infección por COVID-19.

Released: 22-Jun-2021 4:45 PM EDT
Penn Medicine to Use $1M from City of Philadelphia for Additional Community Vaccination Clinics
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine will continue its collaboration with the West and Southwest Philadelphia communities to operate a series of COVID-19 vaccine clinics in partnership with community organizations, faith-based institutions, restaurants, barbershops, and even professional sports teams thanks to $1 million in funding from the City of Philadelphia, in partnership with PMHCC.

Released: 22-Jun-2021 12:30 PM EDT
Political Variables Carried More Weight Than Healthcare in Government Response to COVID-19
Binghamton University, State University of New York

Political institutions such as the timing of elections and presidentialism had a larger influence on COVID-19 strategies than the institutions organizing national healthcare, according to a research team led by a professor at Binghamton University, State University of New York.

22-Jun-2021 12:00 PM EDT
Study Testing How Well COVID-19 Vaccine Prevents Infection and Spread of SARS-CoV-2 Among University Students Now Expands to Include Young Adults Beyond the University Setting
Covid-19 Prevention Network (CoVPN)

The Prevent COVID U study, which launched in late March 2021 to evaluate SARS-CoV-2 infection and transmission among university students vaccinated with the Moderna COVID-19 Vaccine, has expanded beyond the university setting to enroll young adults ages 18 through 29 years and will now also include people in this age group who choose not to receive a vaccine.

Newswise: First Wave COVID-19 Data Underestimated Pandemic Infections
18-Jun-2021 8:30 AM EDT
First Wave COVID-19 Data Underestimated Pandemic Infections
American Institute of Physics (AIP)

Two COVID-19 pandemic curves emerged within many cities during the one-year period from March 2020 to March 2021. Oddly, the number of total daily infections reported during the first wave is much lower than that of the second, but the total number of daily deaths reported during the first wave is much higher than the second wave.

Newswise: PNNL AI Expert Harnesses Open-Source Data to Understand Human Behavior
Released: 22-Jun-2021 9:55 AM EDT
PNNL AI Expert Harnesses Open-Source Data to Understand Human Behavior
Pacific Northwest National Laboratory

PNNL researchers used natural language processing and deep learning techniques to reveal how and why different types of misinformation and disinformation spread across social platforms. Applied to COVID-19, the team found that misinformation intended to influence politics and incite fear spreads fastest.

Released: 22-Jun-2021 8:30 AM EDT
Engineering Nanobodies As Lifesavers When SARS-CoV-2 Variants Attack
Ohio State University

Scientists are pursuing a new strategy in the protracted fight against the SARS-CoV-2 virus by engineering nanobodies that can neutralize virus variants in two different ways.

Released: 21-Jun-2021 3:45 PM EDT
Rare Neurological Disorder Documented Following COVID-19 Vaccination
American Neurological Association (ANA)

In two separate articles in the Annals of Neurology, clinicians in India and England report cases of a rare neurological disorder called Guillain-Barré syndrome after individuals were vaccinated against COVID-19.

Newswise: New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic
17-Jun-2021 12:10 PM EDT
New Analysis reveals link between birthdays and COVID-19 spread during the height of the pandemic
Harvard Medical School

Risk of SARS-CoV-2 infection increased 30 percent for households with a recent birthday in counties with high rates of COVID-19 Findings suggest informal social gatherings such as birthday parties played role in infection spread at the height of the coronavirus pandemic No birthday-bash infection jumps seen in areas with low rates of COVID-19 Households with children’s birthdays had greater risk of SARS-CoV-2 infection than with adult birthdays

Newswise: COVID-19 dual-antibody therapies effective against variants in animal study
Released: 21-Jun-2021 10:05 AM EDT
COVID-19 dual-antibody therapies effective against variants in animal study
Washington University in St. Louis

A study from Washington University School of Medicine in St. Louis suggests that many, but not all, COVID-19 therapies made from combinations of two antibodies are effective against a wide range of virus variants, and that combination therapies appear to prevent the emergence of drug resistance.


Showing results

110 of 5857

close
1.38047